Michael Bowen

Chief Scientific Officer & Co-Founder Kinoxis Therapeutics

Seminars

Tuesday 28th April 2026
How Advanced are New Modalities? Where are the Fields Opening Up?
11:40 am
  • Summarizing the field’s progress across disease areas, including the state of play of different modalities. How do you innovate beyond existing MoAs?
  • Considerations for the right modality: working with more established technologies versus promising new pharmacokinetics
Michael Bowen - 2nd Neuroscience Innovation Partnering & Licensing